Login / Signup
Tro Sekayan
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Ejection Fraction
Poor Prognosis
Mesenchymal Stem Cells
Prognostic Factors
Top Venues
Expert opinion on biological therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tro Sekayan
,
Dana H Simmons
,
Annette von Drygalski
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency).
Expert opinion on biological therapy
(2023)